Phenotypic variability in male patients carrying the mutant ornithine transcarbamylase (OTC) allele, Arg40His, ranging from a child with an unfavourable prognosis to an asymptomatic older adult

J Med Genet. 1996 Aug;33(8):645-8. doi: 10.1136/jmg.33.8.645.

Abstract

In five different Japanese families, we identified six male hemizygotes (aged 6, 9, 15, 17, 56, and 65 years) and a putative candidate (aged 48 years), carrying a mutant allele of the ornithine transcarbamylase (OTC) gene, a G to A substitution at nucleotide 119 in exon 2 generating histidine in place of arginine. OTC activity in the necropsied liver tissue was reduced to approximately 12% of the control and that of COS 1 cells transfected with Arg40His OTC cDNA was 10.2 +/- 1.8% of the control transfected with wild type OTC cDNA. Clinical features ranged from death during a hyperammonaemic attack (a 9 year old) to a 65 year old asymptomatic man. We consider that the amount of protein ingested by these subjects may be one predisposing factor leading to the manifestation of this disease.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Age of Onset
  • Aged
  • Amino Acid Metabolism, Inborn Errors / genetics*
  • Ammonia / blood*
  • Animals
  • COS Cells
  • Child
  • DNA Mutational Analysis
  • Female
  • Genetic Variation
  • Humans
  • Japan
  • Liver / enzymology
  • Male
  • Middle Aged
  • Ornithine Carbamoyltransferase / genetics*
  • Ornithine Carbamoyltransferase Deficiency Disease*
  • Pedigree
  • Phenotype
  • Point Mutation / genetics*
  • Prognosis

Substances

  • Ammonia
  • Ornithine Carbamoyltransferase